This time around, Lyrica’s inventor is developing his Northwestern discoveries at his own biotech
May 27, 2022
Richard Silverman was left in the dark for the last five years of clinical development of the drug he discovered.…
NU‑9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
March 30, 2022
A paper has recently been published demonstrating that AKV9 improves the health of mutant SOD1 mouse upper motor neurons in vitro much better than the FDA-approved ALS drugs riluzole and edaravone, and the combination of AKV9 with either of those drugs provides an additive effect.
AKAVA Founder, Richard B. Silverman receives 2021 Tetrahedron Prize
August 30, 2021
Our Founder, Richard B. Silverman, was selected to receive the 2021 Tetrahedron Prize for Creativity in Organic Chemistry and will present a lecture at the Tetrahedron Symposium in Lisbon, Portugal this June.